Smell and taste dysfunction is associated with higher serum total cholesterol concentrations in Chinese adults

Journal of Nutrition

Volumn 147, Issue 8, 2017, Pages 1546-1551

  Huang, Zhe ^a,b   Huang, Shue ^c   Cong, Hongliang ^a   Li, Zheng ^a,d   Li, Junjuan ^b   Keller, Kathleen L ^c   Shearer, Gregory C ^c   Kris Etherton, Penny M ^c   Wu, Shouling ^b   Gao, Xiang ^c  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Kailuan Hospital   (China)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

^d Tangshan Chinese Medicine Hospital   (China)

Author keywords

Epidemiologic study; General population; Lipids; Lipoproteins; Smell function; Taste function; Total cholesterol

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; ANTILIPEMIC AGENT; CHOLESTEROL;

ADULT; AGE; ARTICLE; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DYSLIPIDEMIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREVALENCE; SMELLING DISORDER; SMOKING; TASTE DISORDER; TRIACYLGLYCEROL BLOOD LEVEL; AGED; BLOOD; CHINA; ODOR; OLFACTION DISORDERS; QUESTIONNAIRE; TASTE; TASTE DISORDERS; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHINA; CHOLESTEROL; CROSS-SECTIONAL STUDIES; HUMANS; HYPOLIPIDEMIC AGENTS; MIDDLE AGED; OLFACTION DISORDERS; PREVALENCE; SMELL; SMOKING; SURVEYS AND QUESTIONNAIRES; TASTE; TASTE DISORDERS;

EID: 85021684610     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.117.250480     Document Type: Article

References (36)

1. Cai H, Maudsley S, Martin B. What is the role of metabolic hormones in taste buds of the tongue. Front Horm Res 42;2014:134-46
2. Martin B, Maudsley S, White CM, Egan JM. Hormones in the nasooropharynx: endocrine modulation of taste and smell. Trends Endocrinol Metab 2009;20:163-70
3. Shin Y-K, Martin B, Golden E, Dotson CD, Maudsley S, Kim W, Jang H-J, Mattson MP, Drucker DJ, Egan JM, et al. Modulation of taste sensitivity by GLP-1 signaling. J Neurochem 2008;106:455-63
4. Kawai K, Sugimoto K, Nakashima K,Miura H, Ninomiya Y. Leptin as a modulator of sweet taste sensitivities in mice. Proc Natl Acad Sci USA 2000;97:11044-9
5. Sun F, Wu S, Wang J, Guo S, Chai S, Yang Z, Li L, Zhang Y, Ji L, Zhan S. Effect of glucagon-like peptide-1 receptor agonists on lipid profiles among type 2 diabetes: a systematic review and network metaanalysis. Clin Ther 2015;37:225-41.e8
6. King A, Yang Q, Huesman S, Rider T, Lo CC. Lipid transport in cholecystokinin knockout mice. Physiol Behav 2015;151:198-206
7. Lubkowska A, Radecka A, Bryczkowska I, Rotter I, Laszczyńska M, Dudzińska W. Serum adiponectin and leptin concentrations in relation to body fat distribution, hematological indices and lipid profile in humans. Int J Environ Res Public Health 2015;12:11528-48
8. Chen M-D, Song Y-M. Effect of lipid infusion on plasma leptin and neuropeptide Y levels in women.Mayo Clin Proc 2002;77:1391-2, 1395
9. Gondivkar SM, Indurkar A, Degwekar S, Bhowate R. Evaluation of gustatory function in patients with diabetes mellitus type 2. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;108:876-80
10. Duffy VB, Backstrand JR, Ferris AM. Olfactory dysfunction and related nutritional risk in free-living, elderly women. J Am Diet Assoc 1995;95:879-84
11. Young Kim W, Hur M, Sook Cho M, Sook Lee H. Effect of olfactory function on nutritional status of Korean elderly women. Nutr Res 2003;23:723-34
12. Ferris AM, Duffy VB. Effect of olfactory deficits on nutritional status. Does age predict persons at risk? Ann N Y Acad Sci 1989;561:113-23
13. Lee WH, Wee JH, Kim D-K, Rhee C-S, Lee CH, Ahn S, Lee JH, Cho YS, Lee KH, Kim KS, et al. Prevalence of subjective olfactory dysfunction and its risk factors: Korean National Health and Nutrition Examination Survey. PLoS One 2013;8:e62725
14. Gouveri E, Katotomichelakis M, Gouveris H, Danielides V, Maltezos E, Papanas N. Olfactory dysfunction in type 2 diabetes mellitus: an additional manifestation of microvascular disease? Angiology 2014;65:869-76
15. Wang L, Cui L, Wang Y, Vaidya A, Chen S, Zhang C, Zhu Y, Li D, Hu FB, Wu S, et al. Resting heart rate and the risk of developing impaired fasting glucose and diabetes: the Kailuan prospective study. Int J Epidemiol 2015;44:689-99
16. Wu Z, Jin C, Vaidya A, Jin W, Huang Z, Wu S, Gao X. Longitudinal patterns of blood pressure, incident cardiovascular events, and all-cause mortality in normotensive diabetic PeopleNovelty and significance. Hypertension 2016;68:71-7
17. Wong JC, Li J, Pavlova M, Chen S,Wu A,Wu S, Gao X. Risk factors for probable REM sleep behavior disorder. Neurology 2016;86:1306-12
18. Ma C, Pavlova M, Liu Y, Liu Y, Huangfu C, Wu S, Gao X. Probable REM sleep behavior disorder and risk of stroke: a prospective study. Neurology 2017;88:1849-55
19. Hoffman HJ, Ishii EK, MacTurk RH. Age-related changes in the prevalence of smell/taste problems among the United States adult population. Results of the 1994 disability supplement to the National Health Interview Survey (NHIS). Ann N Y Acad Sci 1998;855:716-22
20. Huang S, Li J, Shearer GC, Lichtenstein AH, Zheng X, Wu Y, Jin C, Wu S, Gao X. Longitudinal study of alcohol consumption and HDL concentrations: a community-based study. Am J Clin Nutr 2017;105:905-12
21. Zhang Q, Zhou Y, Gao X, Wang C, Zhang S, Wang A, Li N, Bian L, Wu J, Jia Q, et al. Ideal cardiovascular health metrics and the risks of ischemic and intracerebral hemorrhagic stroke. Stroke 2013;44:2451-6
22. Chen CM. Overview of obesity in Mainland China. Obes Rev 2008;9:14-21
23. Liu G, Zong G, Doty RL, Sun Q. Prevalence and risk factors of taste and smell impairment in a nationwide representative sample of the US population: a cross-sectional study. BMJ Open 2016;6:e013246
24. Seubert J, Laukka EJ, Rizzuto D, Hummel T, Fratiglioni L, Bäckman L, Larsson M. Prevalence and correlates of olfactory dysfunction in old age: a population-based study. J Gerontol A Biol Sci Med Sci 2017;7: a018994
25. Peters SAE, Singhateh Y, Mackay D, Huxley RR, Woodward M. Total cholesterol as a risk factor for coronary heart disease and stroke in women compared with men: a systematic review and meta-analysis. Atherosclerosis 2016;248:123-31
26. Doty RL, Philip S, Reddy K, Kerr K-L. Influences of antihypertensive and antihyperlipidemic drugs on the senses of taste and smell: a review. J Hypertens 2003;21:1805-13
27. Karlsson AC, Lindroos AK, Lissner L, Torgerson JS, Carlsson B, Carlsson LMS, Sjöström L. Evidence for gender-specific associations between leptin and olfaction. J Gend Specif Med 2001;5:25-32
28. Takai S, Yasumatsu K, Inoue M, Iwata S, Yoshida R, Shigemura N, Yanagawa Y, Drucker DJ, Margolskee RF, Ninomiya Y. Glucagon-like peptide-1 is specifically involved in sweet taste transmission. FASEB J 2015;29:2268-80
29. Banks WA, During MJ, Niehoff ML. Brain uptake of the glucagon-like peptide-1 antagonist exendin(9-39) after intranasal administration. J Pharmacol Exp Ther 2004;309:469-75
30. Warne JP, Varonin JM, Nielsen SS, Olofsson LE, Kaelin CB, Chua S, Barsh GS, Koliwad SK, Xu AW. Coordinated regulation of hepatic energy stores by leptin and hypothalamic agouti-related protein. J Neurosci 2013;33:11972-85
31. Warne JP, Alemi F, Reed AS, Varonin JM, Chan H, Piper ML, Mullin ME, Myers MG, Corvera CU, Xu AW. Impairment of central leptin-mediated PI3K signaling manifested as hepatic steatosis independent of hyperphagia and obesity. Cell Metab 2011;14:791-803
32. Huynh FK, Neumann UH, Wang Y, Rodrigues B, Kieffer TJ, Covey SD. A role for hepatic leptin signaling in lipid metabolism via altered very low density lipoprotein composition and liver lipase activity in mice. Hepatology 2013;57:543-54
33. Chao P-T, Yang L, Aja S, Moran TH, Bi S. Knockdown of NPY expression in the dorsomedial hypothalamus promotes development of brown adipocytes and prevents diet-induced obesity. Cell Metab 2011;13:573-83
34. Bruinstroop E, Pei L, AckermansMT, Foppen E, Borgers AJ, Kwakkel J, Alkemade A, Fliers E, Kalsbeek A. Hypothalamic neuropeptide Y (NPY) controls hepatic VLDL-triglyceride secretion in rats via the sympathetic nervous system. Diabetes 2012;61:1043-50
35. van den Hoek AM, Voshol PJ, Karnekamp BN, Buijs RM, Romijn JA, Havekes LM, Pijl H. Intracerebroventricular neuropeptide Y infusion precludes inhibition of glucose and VLDL production by insulin. Diabetes 2004;53:2529-34
36. Geerling JJ, Boon MR, Kooijman S, Parlevliet ET, Havekes LM, Romijn JA, Meurs IM, Rensen PCN. Sympathetic nervous system control of triglyceride metabolism: novel concepts derived from recent studies. J Lipid Res 2014;55:180-9